Ocugen, Inc. (OCGN) › Cash & EquivalentsOcugen, Inc. (OCGN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2013: $8.73M2014: $58.53M2015: $30.91M2016: $31.91M2017: $7.08M2018: $1.63M2019: $7.44M2020: $24.04M2021: $94.96M2022: $77.56M2023: $39.46M$39.46M2013Cash & Equivalents (USD)2023Fiscal YearCash & EquivalentsChange YoY2023$39.46M-49.1%2022$77.56M-18.3%2021$94.96M+295.0%2020$24.04M+222.9%2019$7.44M+357.2%2018$1.63M-77.0%2017$7.08M-77.8%2016$31.91M+3.2%2015$30.91M-47.2%2014$58.53M+570.1%2013$8.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share